Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)
PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
August 1, 2024
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2029
Conditions
Non-Small Cell Lung Cancer NSCLC
Interventions
BIOLOGICAL
Anti-Trop2 CAR-NK cell
chemotherapy followed by Trop2 CAR-NK infusion
All Listed Sponsors
lead
Henan Cancer Hospital
OTHER_GOV
NCT06454890 - Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter